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Antibiotic therapy is a double-edged
sword. Since its discovery, it has saved
the lives of billions of patients worldwide,
but the overzealous and very often unjus-
tiﬁed use of antibiotics has led to the ap-
pearance of several multidrug-resistant
bacteria and the increasingly frequent
appearance of invasive fungal infections
in critically ill patients [1, 2]. Further-
more, beyond these indirect effects, anti-
biotics, like any drugs, have undesired
side effects as well. Due to this rationale,
which is also supported by large surveys,
the current guidelines in several ﬁelds of
medicine support antibiotic prophylaxis
for a smaller group of patients than previ-
ous versions. This change was based on a
review of scientiﬁc evidence, which showed
that the risk of adverse reactions to antibi-
otics outweighs the beneﬁts of prophylaxis
for most patients, and this concept
has widely been accepted and articulated
in guidelines released by several societies
[3, 4].
In critical care medicine, antibiotic
prophylaxis has also been questioned in
several ﬁelds such as perioperative care
[5] and acute pancreatitis [4], as well as
in patients with severe burn injuries [6].
Regarding the latter instances, there is a
common feature in that there are many
fewer of these patients compared with
the numbers of those who undergo sur-
gery. Therefore, to undertake large-scale
prospective randomized trials in this
population is extremely difﬁcult. This is
reﬂected by the fact that there are only a
few clinical trials on burn patients, which
were mainly performed in single centers
with a limited number of patients; hence,
robust conclusions are difﬁcult to draw.
To overcome this problem, large multi-
center studies should be designed, but
multicenter studies also have their serious
limitations, especially in intensive care
medicine [7]. Therefore, in intensive care
medicine, we may have to put more effort
and emphasis on large observational
studies and registries on both the national
and international levels.
In this issue of Clinical Infectious Dis-
eases, Tagami et al report on their results
extracted from the Japanese Diagnosis
Procedure Combination database. They
identiﬁed 2893 patients with severe burns
over an almost 3-year period. Patients
were divided into subgroups of those who
received mechanical ventilation within 2
days after admission (n = 692) and those
who did not (n = 2201). From these 2
groups they generated 2 additional pro-
pensity score–matched subgroups: 232
mechanically ventilated patients in the
control (no prophylaxis) group were
compared to 232 ventilated patients
who received antibiotic prophylaxis. Sim-
ilarly, in the nonventilated group, an ad-
ditional 2 subgroups were created with
526 in each arm. There was a huge differ-
ence in 28-day in-hospital mortality be-
tween the ventilated and nonventilated
patients (42.5% vs 6.7%, respectively),
indicating that dividing patients into
groups as deﬁned by the need of mechan-
ical ventilation clearly separated the
whole cohort by severity. This is also un-
derlined by the Charlson comorbidity
index, indicating that approximately 55%
of patients requiring mechanical ventila-
tion had a high (≥2) comorbidity index
compared with <10% in the nonventi-
lated group.
The most interesting ﬁnding of this re-
port is that the authors only found a sig-
niﬁcant association between antibiotic
prophylaxis and 28-day mortality in me-
chanically ventilated patients. There was
an approximate 10% difference in mor-
tality between controls and those receiv-
ing prophylaxis both in the unmatched
(48.6% vs 38.3%) and matched groups
(47.0% vs 36.6%, respectively), and logis-
tic regression and Cox regression analyses
showed a signiﬁcant association between
the use of prophylactic antibiotics and the
lower mortality. In patients without me-
chanical ventilation, 28-day in-hospital
mortality showed no signiﬁcant differ-
ence between any of the subgroups.
Most current guidelines on burn injury
management and antibiotic therapy/pro-
phylaxis either “stay put” or suggest “no
antibiotics without proven infections”
[6, 8]. Not giving antibiotic prophylaxis
to patients with burn injuries, in general,
may be beneﬁcial for the majority of pa-
tients. Indeed, in this study by Tagami
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et al, antibiotic prophylaxis had no effect
on outcome in 76% of patients. However,
these were the less ill patients and, most
important, did not require mechanical
ventilation. On the contrary, in the sicker,
mechanically ventilated subgroup, antibi-
otic prophylaxis might have caused a sig-
niﬁcant reduction in mortality.
As with any retrospective analysis, the
study by Tagami et al has several limi-
tations. However, as mentioned by the
authors, performing large multicenter
prospective randomized trials to over-
come these shortcomings may not be
that easy and would, in fact, be extremely
difﬁcult in patients with burn injuries.
The participating centers should follow
very similar approaches in all details of
care, including sedation, ﬂuid therapy,
ventilation strategy, hemodynamic sup-
port, nurse to patient ratio, and so on,
as all of these have a proven effect on out-
come. Unfortunately, it seems naive to
believe that these conditions could be ful-
ﬁlled; simply recruiting more patients
from more centers may dilute the data,
and increase the noise-to-signal ratio,
and we may end up with yet another mul-
ticenter prospective randomized trial
with nonsigniﬁcant differences between
the study and the control arms, reported
in >70% of large trials in intensive care,
especially where mortality was the prima-
ry endpoint [9]. Therefore, we agree with
the authors that the data extracted from
this large Japanese national database pro-
vide the best attainable evidence on this
issue at present.
However, several very interesting and
important questions are yet to be an-
swered. Although mechanical ventilation
served as a good indicator in dividing this
cohort by severity, it may not be a suf-
ﬁcient (and deﬁnitely not the only)
indicator of administering antibiotic pro-
phylaxis to patients with burns. Using
other tools, such as biomarkers of inﬂam-
mation and organ dysfunction scores, in
addition and in combination may lead
us to more sophisticated care, which can
lead us toward individualized patient
management, when patients get what
they need and not what the protocols dic-
tate they have. It is also important to note
that regarding future studies, mortality
may not be the best outcome measure
as it is confounded by so many factors
in critically ill patients. Due to the limita-
tions of the database in the current study,
we do not know the cause of death for
these patients. Finding the appropriate
endpoints and designing high-quality
prospective studies should be the task of
future research.
Nevertheless, what we know at present
should be enough to tilt the scale toward
refraining from antibiotic prophylaxis in
the severely burned patients in general,
but considering it in those requiring me-
chanical ventilation. Finally, because crit-
ically ill patients are not admitted to
intensive care units in large numbers,
studies are difﬁcult to design and take a
long time to complete. Therefore, the Jap-
anese Diagnosis Procedure Combination
database and the message of the current
analysis serves as an excellent example
that registries are invaluable for clinicians.
The results of the extracted data can reveal
important information and facts, which
can and should change our everyday prac-
tice and may improve patient outcomes.
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